T9	Exp 67 71	that
T10	Exp 81 99	the immunoglobulin
T11	Exp 122 140	the immunoglobulin
T12	Exp 166 168	We
T13	Exp 185 189	that
T14	Exp 190 215	the developmental control
T15	Exp 276 286	the result
T16	Exp 290 312	the combined influence
T17	Exp 356 358	We
T18	Exp 364 368	that
T19	Exp 387 409	the kappa E3' enhancer
T20	Exp 423 443	the pre-B-cell stage
T21	Exp 499 528	The negative-acting sequences
T22	Exp 608 628	the pre-B-cell stage
T23	Exp 630 632	We
T24	Exp 705 709	that
T25	Exp 719 746	the negative-acting segment
T26	Exp 750 772	the kappa E3' enhancer
T27	Exp 801 819	the immunoglobulin
T28	Exp 774 786	This protein
T29	Exp 908 913	which
T30	Exp 873 886	the same gene
T31	Exp 890 906	the YY-1 protein
T32	Exp 923 961	the adeno-associated virus P5 promoter
T33	Exp 1025 1030	which
T34	Exp 977 996	the human homologue
T35	Exp 1000 1023	the mouse delta protein
T36	Exp 1074 1107	The predicted amino acid sequence
T37	Exp 1111 1123	this protein
T38	Exp 1278 1280	it
T39	Exp 1273 1277	that
T40	Exp 1254 1263	this cDNA
T41	Exp 1318 1344	The apparent dual function
T42	Exp 1348 1360	this protein
R8	Coref Anaphora:T9 Antecedent:T3
R9	Coref Anaphora:T24 Antecedent:T4
R10	Coref Anaphora:T28 Antecedent:T4
R11	Coref Anaphora:T30 Antecedent:T5
R12	Coref Anaphora:T29 Antecedent:T31
R13	Coref Anaphora:T33 Antecedent:T35
R14	Coref Anaphora:T37 Antecedent:T35
R15	Coref Anaphora:T42 Antecedent:T35
R16	Coref Anaphora:T38 Antecedent:T40
T1	Protein 46 51	NF-E1
T2	Protein 53 57	YY-1
T3	Protein 59 64	delta
T4	Protein 698 703	NF-E1
T5	Protein 853 858	NF-E1
T6	Protein 894 898	YY-1
T7	Protein 963 968	NF-E1
T8	Protein 1010 1015	delta
